These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 28892734)

  • 21. A Longitudinal (6-week) 3T (1)H-MRS Study on the Effects of Lithium Treatment on Anterior Cingulate Cortex Metabolites in Bipolar Depression.
    Machado-Vieira R; Gattaz WF; Zanetti MV; De Sousa RT; Carvalho AF; Soeiro-de-Souza MG; Leite CC; Otaduy MC
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2311-7. PubMed ID: 26428274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraindividual changes in brain GABA, glutamate, and glutamine during monitored abstinence from alcohol in treatment-naive individuals with alcohol use disorder.
    Prisciandaro JJ; Schacht JP; Prescot AP; Brenner HM; Renshaw PF; Brown TR; Anton RF
    Addict Biol; 2020 Nov; 25(6):e12810. PubMed ID: 31373138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topiramate raises anterior cingulate cortex glutamine levels in healthy men; a 4.0 T magnetic resonance spectroscopy study.
    Moore CM; Wardrop M; deB Frederick B; Renshaw PF
    Psychopharmacology (Berl); 2006 Oct; 188(2):236-43. PubMed ID: 16944105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ketamine reverses stress-induced depression-like behavior and increased GABA levels in the anterior cingulate: an 11.7 T 1H-MRS study in rats.
    Perrine SA; Ghoddoussi F; Michaels MS; Sheikh IS; McKelvey G; Galloway MP
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():9-15. PubMed ID: 24246571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of effect of citalopram on magnetic resonance spectroscopy measures of glutamate and glutamine in frontal cortex of healthy volunteers.
    Taylor MJ; Norbury R; Murphy S; Rudebeck S; Jezzard P; Cowen PJ
    J Psychopharmacol; 2010 Aug; 24(8):1217-21. PubMed ID: 19423614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurochemistry of major depression: a study using magnetic resonance spectroscopy.
    Godlewska BR; Near J; Cowen PJ
    Psychopharmacology (Berl); 2015 Feb; 232(3):501-7. PubMed ID: 25074444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response.
    Block W; Träber F; von Widdern O; Metten M; Schild H; Maier W; Zobel A; Jessen F
    Int J Neuropsychopharmacol; 2009 Apr; 12(3):415-22. PubMed ID: 18845018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the change in glutamate to GABA ratio correlate with change in depression severity? A randomized, double-blind clinical trial.
    Narayan GA; Hill KR; Wengler K; He X; Wang J; Yang J; Parsey RV; DeLorenzo C
    Mol Psychiatry; 2022 Sep; 27(9):3833-3841. PubMed ID: 35982258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutamatergic and neurometabolic alterations in chronic cocaine users measured with (1) H-magnetic resonance spectroscopy.
    Hulka LM; Scheidegger M; Vonmoos M; Preller KH; Baumgartner MR; Herdener M; Seifritz E; Henning A; Quednow BB
    Addict Biol; 2016 Jan; 21(1):205-17. PubMed ID: 25600822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anterior cingulate cortex and cerebellar hemisphere neurometabolite changes in depression treatment: A 1H magnetic resonance spectroscopy study.
    Chen LP; Dai HY; Dai ZZ; Xu CT; Wu RH
    Psychiatry Clin Neurosci; 2014 May; 68(5):357-64. PubMed ID: 24393367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression.
    Salvadore G; van der Veen JW; Zhang Y; Marenco S; Machado-Vieira R; Baumann J; Ibrahim LA; Luckenbaugh DA; Shen J; Drevets WC; Zarate CA
    Int J Neuropsychopharmacol; 2012 Sep; 15(8):1063-72. PubMed ID: 22040773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repetitive Transcranial Magnetic Stimulation-Associated Changes in Neocortical Metabolites in Major Depression: A Systematic Review.
    Gonsalves MA; White TL; Barredo J; Fukuda AM; Joyce HE; Harris AD; Carpenter LL
    Neuroimage Clin; 2022; 35():103049. PubMed ID: 35738081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain glutamate in medication-free depressed patients: a proton MRS study at 7 Tesla.
    Godlewska BR; Masaki C; Sharpley AL; Cowen PJ; Emir UE
    Psychol Med; 2018 Jul; 48(10):1731-1737. PubMed ID: 29224573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy.
    Simpson HB; Shungu DC; Bender J; Mao X; Xu X; Slifstein M; Kegeles LS
    Neuropsychopharmacology; 2012 Nov; 37(12):2684-92. PubMed ID: 22850733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progressive decrease of N-acetylaspartate to total creatine ratio in the pregenual anterior cingulate cortex in patients with major depressive disorder: longitudinal 1H-MR spectroscopy study.
    Tae WS; Kim SS; Lee KU; Nam EC; Koh SH
    Acta Radiol; 2014 Jun; 55(5):594-603. PubMed ID: 24031048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression.
    Sanacora G; Gueorguieva R; Epperson CN; Wu YT; Appel M; Rothman DL; Krystal JH; Mason GF
    Arch Gen Psychiatry; 2004 Jul; 61(7):705-13. PubMed ID: 15237082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medial prefrontal cortex neurotransmitter abnormalities in posttraumatic stress disorder with and without comorbidity to major depression.
    Swanberg KM; Prinsen H; Averill CL; Campos L; Kurada AV; Krystal JH; Petrakis IL; Averill LA; Rothman DL; Abdallah CG; Juchem C
    NMR Biomed; 2024 Nov; 37(11):e5220. PubMed ID: 39054694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo.
    Das P; Tanious M; Fritz K; Dodd S; Dean OM; Berk M; Malhi GS
    Aust N Z J Psychiatry; 2013 Apr; 47(4):347-54. PubMed ID: 23341476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissociation of glutamate and cortical thickness is restricted to regions subserving trait but not state markers in major depressive disorder.
    Li M; Metzger CD; Li W; Safron A; van Tol MJ; Lord A; Krause AL; Borchardt V; Dou W; Genz A; Heinze HJ; He H; Walter M
    J Affect Disord; 2014 Dec; 169():91-100. PubMed ID: 25173431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS.
    Valentine GW; Mason GF; Gomez R; Fasula M; Watzl J; Pittman B; Krystal JH; Sanacora G
    Psychiatry Res; 2011 Feb; 191(2):122-7. PubMed ID: 21232924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.